로딩 중…
지수 로딩 중…
Gossamer Bio, Inc.
GOSS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$0.17-6.15%
2026-06-18
Price Chart
Gossamer Bio, Inc.-86.98%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $39M |
| Revenue | $56M |
| Net Income | $-180M |
| Total Assets | $129M |
| Net Assets | $29M |
| Value | |
| P/B | 1.34x |
| P/S | 0.71x |
| FCF Yield | -431.96% |
| Profitability | |
| Op. Margin | -321.92% |
| Revenue Growth | 71.45% |
| Financial Health | |
| Debt Ratio | 984.61% |
| Total Debt | $203M |
| FCF | $-170M |
| Cash | $41M |
| Current Ratio | 2.20x |
| Performance | |
| 1Y Return | -86.98% |
| 1M Return | -15.62% |
| From 52W High | -95.66% |
| 1Y MDD | -95.88% |
| Trading | |
| Volume | 22,712,462 shares |
| Trading Value | $4M |
| Per Share | |
| EPS | $-0.75 |